Stonehenge Partners Corp

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Stonehenge Partners Corp
CRD #333491
SEC #802-131608
CIK #0001638279
AUM
Employees
Phone614-246-2500
Address191 W Nationwide Blvd
Columbus, OH 43215
Source [IAPD] [EDGAR] [Website]
Total AUM ($)
1.00.80.60.40.20.02011201620212026
Type Form D Funds Date Sold ($M) AUM ($M)
PE Stonehenge Opportunity Fund III-B LP 2024-11-11 6.5
PE Stonehenge Opportunity Fund III LP 2024-11-11 39.6
Other Stonehenge Opportunity Fund IV LP [2024-11-11] 81.5 266.2
Other Stonehenge Opportunity Fund V LP [2024-11-11] 139.1 281.3
AUM Breakdown Accounts AUM ($)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 0 0.0
By Discretionary
Discretionary 0 0.0
Non-Discretionary 0 0.0
Total 0 0.0
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 0.0
Total 0 0.0
Form D Directors # Filings # Firms 2011 - 2025
Peter Davies 19
David Meuse 13
Thomas Utgard 2
Robert Eversole 2
Corp Stonehenge Partners 1
Stephen Kimpel 1
Michael Endres 1
Stonehenge Equity Partners V 1
Andrew Bohutinsky 1
EDGAR Form CIK 2011 - 2025
3 [0001638279]
4 [0001638279]
SC 13G [0001638279]
Form 13D/13G Filer Form 13D/13G Subject Filed
Stonehenge Partners LLC Ritter Pharmaceuticals Inc [2016-02-25]
Form 3/4/5 Subject 2011 - 2025
Stonehenge Partners LLC
Qualigen Therapeutics, Inc.
Terms | Privacy | Guide
tony@aum13f.com